Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus for Vitiligo Vulgaris
NCT00372307Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pimecrolimus in Vitiligo, sponsored by Ghent University Hospital. Primary endpoint: Repigmentation percentage of the reference lesion at 6 months. Started May 2004; status: completed.
02
Drugs
pimecrolimus
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT00372307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372307.